ClinicalTrials.Veeva

Menu

French Translation and Validation of the PEYronie's Disease QUESTionnaire (FRAPEYQUEST)

T

Toulouse University Hospital

Status

Completed

Conditions

Peyronie Disease

Treatments

Other: FRAnçaise du PEYronie's Disease QUESTionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05768867
RC31/23/0012
2023-A00219-36 (Registry Identifier)

Details and patient eligibility

About

This study is a prospective cohort dedicated to peyronie's disease. The aim is to validate the french translation of the peyronie's disease questionnaire. The primary endpoint is the response rate to the questionnaire.

Enrollment

30 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient with Peyronie's Disease clinically diagnosed during a consultation, with palpation of at least one plaque

Exclusion criteria

  • Patient refusing to participate
  • Patient with difficulties in understanding the French language.
  • Protected persons referred to in articles L.1121-6 to L.1121-8 of the public health code

Trial contacts and locations

1

Loading...

Central trial contact

Eric Huyghe, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems